tiprankstipranks
Trending News
More News >
Demant (WILYY)
OTHER OTC:WILYY
US Market

Demant (WILYY) Earnings Dates, Call Summary & Reports

Compare
6 Followers

Earnings Data

Report Date
Aug 18, 2026
TBA (Confirmed)
Period Ending
2026 (Q2)
Consensus EPS Forecast
Last Year’s EPS
0.39
Same Quarter Last Year
Based on 0 Analysts Ratings

Earnings Call Summary

Q4 2025
Earnings Call Date:Feb 03, 2026|
% Change Since:
|
Earnings Call Sentiment|Neutral
Balanced message: the company delivered solid cash generation, successful product launches (Zeal) and an acquisition that strengthens its Hearing Care footprint, while presenting a clear 2026 growth and profitability roadmap. At the same time, near-term profitability is pressured by a softer hearing aid market (especially in the U.S.), ASP/headwind mix effects, FX impacts, elevated leverage after the KIND acquisition, and planned restructuring/special items. Management expects the cost program and KIND contribution to support margin recovery in 2026, but risks (market softness, competitive pressure and FX) remain.
Company Guidance
Demant guided 2026 organic growth of 3–6% and EBIT before special items of DKK 4.1–4.5 billion, based on an assumed global hearing‑aid market growing 2–4% in value; key modeling assumptions include acquisitive growth of 8%, FX of -2% (an FX EBIT headwind of DKK 200m, split H1/H2), an effective tax rate of 23% and a pause of share buybacks while targeting deleveraging from a 3.4% year‑end gearing back to 2–2.5% within 18–24 months. The company expects ~DKK 250m of EBIT improvement from a 2‑year cost program in 2026 (part of DKK 500m run‑rate savings from 2028+), will recognize DKK 325m of special items in 2026 (DKK 125m KIND integration + DKK 200m restructuring, plus a further DKK 100m in 2027), anticipates KIND to contribute roughly DKK 300m (≈DKK 275m on an 11‑month basis) to EBIT, models DKK 25m tariff impact, and plans actions affecting ~700 people in 2026 (150 in Demant) with the majority of savings phased into H2.
Group revenue and growth momentum
Full-year 2025 organic growth of 2% (5% in local currencies); second half organic growth improved to 4%, showing sequential recovery across all three business areas.
Strong cash generation
Full-year cash flow from operations DKK 3.85 billion and free cash flow above DKK 3.0 billion; H2 cash flow from operations DKK 2.3 billion and H2 free cash flow ~DKK 2.0 billion.
KIND acquisition expands Hearing Care footprint
Acquisition of the KIND Group closed in December 2025, significantly expanding position in Germany (expected #1 in Hearing Care) and expected to contribute ~DKK 300 million to EBIT before special items in 2026 (11 months ~DKK 275 million in modelling).
Successful product launch — Oticon Zeal
Oticon Zeal (launched Oct 2025 in selected markets) received very positive feedback, lifted sales in the first four European markets, increased uptake among first-time users and also boosted sales of other portfolio products; rollout progressing (U.S. launched, Canada and France upcoming).
Hearing Care and Diagnostics Q4 strength
Hearing Care: Q4 local currency revenue up 17% and organic growth ~5% in the quarter (tailwind from one month of KIND); Diagnostics: Q4 organic growth of 8% in local currencies and strong performance in U.K., Germany, U.S./Canada (driven by services and consumables) and Australia (instruments).
Clear 2026 financial targets and profitability program
2026 guidance: organic growth 3%–6% and EBIT before special items DKK 4.1–4.5 billion. Company-wide cost initiative expected to deliver ~DKK 250 million EBIT impact in 2026 and ~DKK 500 million from 2028 onward.
Sustainability and people metrics
Improved lives reached 12 million persons; scope 1 & 2 GHG emissions down 16% vs baseline (target 46% by 2030); gender diversity in top management 33% (target >35% by 2030); near-complete roll-out of people-readiness metrics.

Demant (WILYY) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

WILYY Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Aug 18, 2026
2026 (Q2)
- / -
0.386
Feb 03, 2026
2025 (Q4)
- / -
0.401
Aug 12, 2025
2025 (Q2)
- / 0.39
0.409-5.62% (-0.02)
Feb 05, 2025
2024 (Q4)
- / 0.40
0.3951.52% (<+0.01)
Aug 14, 2024
2024 (Q2)
- / 0.41
0.189116.40% (+0.22)
Feb 05, 2024
2023 (Q4)
- / 0.40
0.31425.80% (+0.08)
Aug 16, 2023
2023 (Q2)
- / 0.19
0.338-44.08% (-0.15)
Feb 07, 2023
2022 (Q4)
- / 0.31
0.45-30.22% (-0.14)
Aug 16, 2022
2022 (Q2)
- / 0.34
0.4-15.50% (-0.06)
Feb 08, 2022
2021 (Q4)
- / 0.45
0.33135.95% (+0.12)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

WILYY Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Feb 03, 2026
$17.56$15.70-10.59%
Aug 12, 2025
$19.67$19.79+0.62%
Feb 05, 2025
$19.64$18.40-6.30%
Aug 14, 2024
$19.28$19.67+2.03%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Demant (WILYY) report earnings?
Demant (WILYY) is schdueled to report earning on Aug 18, 2026, TBA (Confirmed).
    What is Demant (WILYY) earnings time?
    Demant (WILYY) earnings time is at Aug 18, 2026, TBA (Confirmed).
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is WILYY EPS forecast?
          Currently, no data Available